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Abstract
Background: Antiretroviral (ARV) drugs have become the cornerstone of HIV (Human Immunodefi ciency Virus) care 
and treatment. Its use has led to a marked reduction in AIDS (Acquired Immune Defi ciency Syndrome) related morbidity 
and mortality. However, more than fi ve years after their introduction few HIV infected people in Nepal are receiving 
ARVs. 
Objective: The main aim of this study is to identify barriers and obstacles to providing and expanding ARV programmes 
in Nepal. 
Materials and methods: A qualitative approach consisting of in-depth interviews with three groups of stakeholders: 
policy makers, ARV service providers and ARV recipients were carried out. The transcripts were analysed using a 
thematic approach.
Results: The estimated number of people in need was high compared with people currently receiving ARV in Nepal. With 
regards to the proper distribution of the ARVs, the main problems identifi ed in the interviews were: lack of infrastructure, 
lack of human resources, fi nancial constraints, programmatic problems, weak leadership and management at national 
level, poor cooperation between management structures, geographical barriers, lack of awareness and low uptake of 
counselling and/or testing, stigmatization and discrimination felt by the health workers and the community, lack of 
coordination and limited access to services.
Conclusion: Limited resources and administrative capacity coupled with strong underlying needs for services pose 
serious challenges to the government.  Despite this, better use could be made of existing services and resources to help 
benefi t more people from ARV. 
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 The spread of HIV (Human Immunodefi ciency Virus) and AIDS (Acquired Immune Defi ciency 
Syndrome) has reached a pandemic form within a 
short span of time, affecting 33 million people across 
the globe, 2.7 million people became infected with the 
virus and 2 million people died of HIV-related causes1.
HIV/AIDS is a major public health concern in Nepal2, 
since its fi rst case was reported in 19883. As of August 
2008, the National Centre for AIDS and STD (Sexually 
Transmitted Disease) Control (NCASC) in Nepal 
reported that there were 12415 HIV positive people, 
2037 People living with AIDS and 505 AIDS cases were 
reported to have died4.  With poor surveillance systems 
and the lack of access to quality voluntary counselling 
and testing services, these prevalence fi gures are likely 
to be a gross under estimate. UNAIDS estimated that 
75,000 people were living with HIV/AIDS and 5100 
AIDS related deaths had occurred till the year 20065. 
The key sources of HIV infection were sex workers 
(48%), injecting drugs (21%) and housewives (19%). 
Similarly, HIV infection in Nepal mainly is found (80%) 
in the younger age groups of 20 to 39 years4. 
Antiretroviral (ARV) treatment programme in 
Nepal
Antiretroviral drugs have become the cornerstone of care 
and treatment for HIV infected people. Antiretroviral 
regimens improve survival rates and lower the 
incidence of opportunistic infections of HIV infected 
people.  The use of ARV has led to a marked reduction 
in AIDS related morbidity and mortality, in countries 
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where ARVs are widely available are experiencing clear 
declines in AIDS related death6, this has led to a 70% 
decline in deaths due to HIV/AIDS5. 
The HIV/AIDS treatment programme is relatively new 
in Nepal.  In 2003 the government started giving free 
ARV drugs in a public hospital and national guidelines 
for ARV treatment were developed in 2004. According 
to United Nation General Assembly Special Session 
(UNGASS), only 1 out of 100 of people with HIV/
AIDS received free ARV from 17 different sites through 
either the public or private health care system, which is 
very low as compared to other countries7. However, less 
development has existed in the area of HIV treatment, 
care and support despite the fact that the estimated 
number of PLWHA (People Living with HIV/AIDS) in 
Nepal is high. So far, no research has been published 
to establish the range of problems and barriers to the 
expansion of ARV treatment programme in Nepal. 
Other countries have reported problems and barriers to 
the expansion of ARV services. These include: shortage 
of human resources, inadequate health infrastructure, 
lack of funding, inadequate access to treatment and 
stigma and discrimination. The present research aims to 
establish current problems and barriers to the expansion 
of ARV treatment programme in Nepal, including 
problems in delivering of ARV and barriers to expanding 
existing treatment programme. 
Materials and methods  
This qualitative study used face-to-face interviews 
with stakeholders. The qualitative approach addresses 
‘how and why’ questions rather than: ‘how many?’, 
and examines people in their natural setting, using their 
own natural set of categories8. This method is described 
as a means for better understanding a complex social 
phenomenon and it explores new topics and also to probe 
further into complex issues through methods that are not 
quantifi able into numbers9. Similarly, this method can be 
used for its own sake to explore a particular issue when 
a research problem has not been previously explored.10 
This method contributes to depth and detail of enquiry 
and conveys a deeper feeling for the persons studied11. 
In this regards, this methodology seeks to gather the 
information of problems and barriers to ARV service 
expansion. Thus, it can best be captured by using this 
methodology. The interviews were semi-structured; the 
fi rst author used an interview schedule to ensure all key 
issues were addressed whilst leaving space adds follow-
up questions if and when appropriate.
Purposive sampling was used for selecting participants. 
Purposive sampling is often used when the researcher 
has specifi c requirements for the sample and picks a 
subject who meets these strict criteria12. However, “there 
is no hard and fast rule for sample size for qualitative 
study”13.  
A total of 18 respondents of three different stake holders 
groups were interviewed: fi ve key policy makers; ten 
ARV service providers (4 doctors, 3 nurses and 3 people 
from Non Government Organizations) and three ARV 
recipients. ARV service providers and ARV recipient 
participants were from three ARV providing institutions 
and two Non Government Organizations (NGOs) 
located in central region. The service providers, doctors 
and nurses involved ARV treatment had commenced 
their services since the start of these services in Nepal. 
Similarly, the ARV recipients participating in our study 
had been taking ARV for over nine months. 
Interviews were tape recorded with the consent of the 
respondents. The interviews were in Nepali and then 
translated into English for analysis. A thematic analysis 
was employed to categorise the data. 
Before conducting the main study, a pilot study14 was 
conducted with two nursing staffs and a doctor at 
different hospitals in Kathmandu than the study site to 
help design appropriate interview schedules and key 
questions for the main interviews. For each respondent, 
written consent was obtained after clarifying the 
objectives of the study prior to the interview with them. 
Moreover, permission was obtained from the Nepal 
Health Research Council. 
Analysis of results
The main themes related to problems of and barriers to 
ARV services provision are listed in Table 1. It should 
be noted that these themes are not mutually exclusive 
and that there was considerable overlap between some 
of the themes.
1. Problems related to infrastructure 
Inadequate basic infrastructure was a key underlying 
problem which hinders the current services provision 
as well as potential expansion of ARV treatment.  This 
theme consisted of four sub-themes (see Table 1).
- Physical facilities and space 
Lack of physical facilities and space were often major 
limitations to providing appropriate ARV services. 
Most of the respondents thought that it is not possible to 
expand ARVs services without improving infrastructure 
in these hospitals, as the ARV programme had to be 
incorporated in public hospitals.  For example, one 
doctor stated that:
We are serving ARV treatment in a very diffi cult way 
because we are serving in a very congested space. 
How can we add more patients without place for 
managing them? (Clinician, Kathmandu)
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PLWHA also stated that hospitals had space problems, 
for example: 
Lab and radiology departments are very rushed 
with outpatients and inpatients.  There is not even 
waiting area and there is diffi culty in maintaining 
confi dentiality for HIV positive people in public 
hospitals. (PLWHA, outside Kathmandu)
- Diagnostic services
Diagnostic facilities must be available if ARV 
programmes are to run successfully in Nepal. However, 
diagnostic services are restricted, especially the ability 
to do a CD4 count. The CD4 level in cells is needed 
to diagnose HIV in earlier stage of the disease.  The 
majority of respondents made comments similar to this 
health care worker: 
We do not have our own lab. Blood needs to be sent 
to  central lab and  it takes time because whole HIV 
people are depended on only this central lab for CD4 
test where is a rush and it takes more time to get 
results. (Nursing Staff, Kathmandu)
Policy makers saw a similar problem, for example: 
Still we do not have adequate pathology (labs) setup 
for CD4 cell count and the existing set up has always 
been complained. (MoH)  
One doctor highlighted linked the lack of CD4 count 
facilities out with Kathmandu with travel issues for 
patients;
Having CD4 cell count machine is fundamental to 
start ARV. PLWHAs need to go Kathmandu for CD4 
count which is major problem faced by patients and 
the hospitals to start ARV…it is diffi cult to cater 
ARV service with out adequate diagnostic services. 
(Clinician, outside Kathmandu)
- Lack of staff
ARV treatment is staff intensive as it requires close 
supervision and monitoring of patient compliance 
with treatment. Many interviewees agreed there was a 
shortage of health care workers to make ARV treatment 
work.  One director highlighted the problems of trained 
manpower.
There is great need for trained, well motivated 
medical personnel (doctors, nurses, counsellor) 
to assist in the hospitals and in communities too. 
(NCASC)
Similarly a doctor highlighted insuffi cient human 
resource planning:
There is no additional staff provided by MoHP for 
ARV service, but NCASC started the programme 
without planning…we always need to adjust in two 
places because there is huge pressure on inpatients 
department and we need to attend them rather than 
attending to ARV patients. But ARV patients need 
to be given more time for counselling as well as the 
need to maintain confi dentiality. (Clinician, outside 
Kathmandu)
Overworked doctors and nurses as well as the frequent 
transfer of trained staff to other hospitals also hinder the 
provision of services. 
- Financial constraint
Antiretroviral drugs are provided by the government 
free of charge but development of infrastructure in 
existing health service is an underlying fundamental 
problem for the government. Whilst individual patients 
have diffi culty to manage out-of-pocket expenses, such 
as additional costs incurred through travel, diagnostic 
tests, nutritional and other users charges.  Comments 
often related to the travel cost and time for people 
living far away from Kathmandu were also made by the 
participants, for example:
Not all services are free of charges only ARVs are 
providing in the central level hospitals and is limited 
in private organizations but clients are in remote 
areas. Who will provide non medicine costs? ARVs 
are a life time treatment. …Implicit costs are main 
problems to limit access of ARVs to PLWHAs. 
(Coordinator, NGO)
One PLWHA highlighted that the cost of travel to 
services in Kathmandu is more than six (?) times the 
average daily income of many Nepalese, for example;
So many remote areas people were dying without 
getting ARVs because they do not have money to 
come by themselves to hospital. They need money 
for transportation, diagnostics and living ... (my) 
bus fare is NRs.1200 and what about other living 
and tests cost. If calculated it is a huge amount of 
cost  to us……NCASC is just advertising to provide 
ARV free of cost but nobody has thought about the 
cost implication (e.g. travel, diagnostic)…we do not 
have fi nancial support and there are no ways to earn 
(PLWHA, Kathmandu).  
One policy level interviewee argued that the fi nancial 
problem is stated in two sides, supply and demand:
In the supplier side government is not able to expand 
ARV in each and every hospital immediately, which 
takes huge cost….. on the demand side, additional 
costs like  travel cost, diagnostic test costs are 
prohibiting the PLWHA to come hospitals and testing 
their blood which is not  possible to arrange free of 
cost by the Ministry. (MoHP)
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The costs of ARV treatment emerged as a chief concern 
for all interviewees. HIV is chronic in nature, and when 
properly treated it requires a lifetime commitment and 
consequently there is a need to fi nd sustainable funding 
for treatment programmes. 
2. Problems related to management
- Leadership  
Strong leadership at all levels of society is crucial for an 
effective response to the epidemic. Leadership involves 
personal commitment and concrete actions. Inspiring 
and empowering leadership at all levels is needed. 
Most respondents commented on the frequent change 
in directorship of the NCASC, for example:
Continuous changing of NCASC director is the main 
hurdle of HIV/AIDS programme management and 
treatment of PLWHAs. The MoHP should not make 
the NCASC as a “political football ground” by 
changing director. (Coordinator, NGO)
Lack of visionary leadership and instability of the 
director in NCASC …. A new person needs at least 
six months to know the basic functional activities of 
the organization but with in one year the director will 
be changed four times. So how can MoHP/NCASC 
meet millennium development goals and universal 
coverage of ARVs for Nepalese people? (Clinician, 
Kathmandu)
- Cooperation between government and NGOs
Effective coordination is vital for sustainable 
programmes different levels of the health system. The 
health system should not be subdivided into many parts 
as it decreases its effi ciency, as one doctor suggested:
The HIV/AIDS programme itself is not set 
programme to date, NCASC is not able to carry 
out good coordination in public (hospitals), private 
(NGOs) and community-based organizations; but to 
expand the service, NCASC needs to learn from the 
ARV success story in Bangkok or Brazil. (Clinician, 
Kathmandu)
- Health service provision
A number of interviewees raised the concern that the 
provision of ARV treatment is not suitable. A policy 
maker stated that:
Our treatment procedure itself is not suitable, i.e. 
It is based on a CD4 test. Without this…there is 
no provision to start ARV….if you based on that 
protocol we cannot expand ARV service to all the 
eligible people. (MoHP)
Whilst an interviewee from NCASC highlighted referral 
and communication problems:
There is no referral mechanism developed in clinical 
sites…until and unless we make ARVs services 
accessible. The provider has a good referral 
mechanism, but we have not seen it to date and there 
is very poor coordination. (NCASC)
Interviewees did not only refer to the provision of ARV 
drugs services, but also the lack of counselling, for 
example:
Most of people do not know they are infected; and 
so they do not get any treatment or drugs. ..People 
are diagnosed HIV after very serious conditions, 
..providing enough HIV counselling and testing 
services encourage people to use these services. 
..still in many societies of Nepal, has fear of stigma 
and discrimination remains a serious barrier of VCT 
(Voluntary Counselling & Testing) services. (NCASC)
Some interviewees mentioned the general health care 
problem in Nepal, namely that doctors are not available 
when they should be, for example:
You know, the doctors and other health personnel 
are always unavailable in hilly and mountain district 
hospitals and Primary Healthcare Centres (PHC) in 
Nepal…….who will refer them to go in hospital for 
ARV? (PLWHA, Kathmandu)
It was found that PLWHA often had inadequate 
knowledge about counselling, and counselling and 
testing services are diffi cult to access for PLWHA. 
3. Problems related to access
- Geographical barriers and access
Most interviewees found that distance is a barrier, 
which needs to be addressed when expanding ARV sites 
to offer access to all eligible people.  
The real ARV needy people are without services and 
treatment services are only focused in urban areas but 
we need in (=rural districts) people because how to 
reach Dhangadi (district) from there, who’ll bear their 
additional cost? (Coordinator, NGO)
Many PLWHAs are living without treatment……….
the existing ARV institutions are mostly constrained in 
urban areas… we need ARV treatment in rural districts 
because it is diffi cult to reach existing ARV institutions 
from remote areas and also it takes a while…… there 
are no road, no vehicles in hilly districts.  (Coordinator, 
NGO)
Similarly, participants stated that there is very limited 
access to ARVs treatment for PLWHA. Again rural 
areas were seen as particularly problematic:
In so many remote areas people are dying without 
getting ARVs … they do not have access to the 
hospital. ARV is limited to only a few hospitals which 
310
are all in urban areas. Think about 80% people 
that are living in rural areas, how to access to all 
PLWHA?  (PLWHA, Kathmandu)
4. Problems related to stigma
Stigma found to discourage people from coming for 
testing and majority of respondents stated that;
Still rural people do not want to go to the hospital 
and laboratory to test their status because they say 
that people will recognize them as a HIV positive 
person. (PLWHA, Kathmandu)
Others refer to the general ignorance still portrayed by 
some people who refer to HIV as the Bombay disease:
Still Mid- Far western region people (Doti, Achham 
districts) regard HIV as a “Bombay Disease”….
one patients came and asked me….doctor give me 
injection for Bombay Disease. (MoHP)
Nonetheless, stigma found to discourage people from 
coming for testing. For example;
Why are rural people still not diagnosed and on ARV 
treatment? Because most of them do not know where 
to go and they are not ready to ask for information in 
the community because people will take it negatively 
about their status and he/she will be avoided them 
from society due their HIV status. (Clinician, 
Kathmandu)
Still HIV positive people in Nepal are perceived 
negatively…sex workers, drug users in Nepal are often 
taken negatively and discriminated. (NCASC)
High level discrimination against HIV infected persons, 
identifi cation and willingness to undergo diagnostic 
procedures puts a serious barrier for many people. 
Table 1: Key problems and barriers to improved ARV delivery in Nepal
Problem related to infrastructure:1. 
-      Physical facilities and space
-      Diagnostic services
-      Staffi ng
-     Financial constraint 
Problems related management 2. 
- Weak leadership
- Cooperation between Government and NGOs
- Health services  provision (ARV provision, counselling, testing)
3.    Problems related to access
- Geographical barriers and poor access
4.    Problems related to stigma 
Discussion
This study highlights three key factors: resource 
constraint, cultural/societal issues and management. 
Each factor is discussed in more detail below:
1.  Resource constraint  
ARV treatment is a complex process which needs 
continued close supervision by health professionals 
through laboratory facilities. Most respondents stated 
that there were major infrastructural problems and 
barriers to expansion of ARV services, including, lack of 
proper laboratory services (e.g. CD4 machine & space) 
There was only one functioning CD4 counting machine 
in Kathmandu. Clients from other parts have to travel 
to the capital in order to get a CD4 cell count, which 
they need to qualify for ARV drugs and to monitor their 
treatment. 
Infrastructural problems were also faced in Kenya, 
Tanzania, Uganda and Mozambique15 and inadequate 
laboratory facilities and poor patient care infrastructures 
were major barriers to expansion of treatment in 
Africa16.   Similarly, shortage of human resources is a 
global issue in most resource-constrained countries17. 
In Nepal we found lack of staff and overworked doctors 
and nurses. At the same time, there was frequent transfer 
of trained health personnel.  Shortage of appropriately 
trained health care staff is also reported in countries in 
Asia  (e.g. China, India, Thailand) and Sub-Saharan 
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Africa (e.g. Kenya, Tanzania, Uganda, Ghana)18,19, 20,21. 
Thus, adequate trained staff should be managed fi rst 
before services are expanded otherwise it will be very 
challenging to provide services to the increasing number 
of PLWHA. Adequately trained human resources are 
an important component for the delivery of quality 
health services. Frequent absence of health personnel in 
districts is another general health system problem stated 
by interviewees. This might be due to poor working 
environment, poor incentives and lack of opportunities 
for career development as well as insecurity of life in 
districts due to violence. 
Antiretroviral drugs are provided by Nepal government 
free of charge but the interviewees argued that patients 
are burdened by the additional costs (transportation costs, 
diagnostic costs etc.). One Nepalese study revealed that 
the economic conditions of PLWHA’s households are 
worse than non-PLWHA’s households22. Poverty affects 
all aspects of care, including patient’s ability to pay for 
transport fares, food and diagnostic tests. The majority 
of interviewees worried about these costs in the light 
of the chronic nature of HIV disease, and the cost 
associated with long-term treatment. Similar fi ndings 
were reported in Thailand where pre and post ARV test 
costs were major constraints to expanding ARVs21 and 
Botswana where, 12 percent of ARV clients did not 
receive ARVs treatment because they could not afford 
to pay for transport23. These fi ndings suggest that many 
HIV positive people have signifi cant non-drugs related 
fi nancial problems, even though their government is 
providing ARV free of costs. 
The government has limited funds for the expansion 
of infrastructure, human resources and operating costs. 
MoHP is the prime provider of funds funded of the health 
sector and a substantial contribution is made by NGOs 
in Nepal24. Furthermore, an expansion of treatment sites 
will not be possible without sustainable fi nancing for 
the expansion of infrastructures and capacity building 
as well as addressing implicit costs of the ARV clients.
2. Socio-cultural problem
Interviewees reported that stigma and discrimination 
were major problems and barriers to the expansion of 
ARV to remote districts in Nepal.  Moreover, high levels 
stigma and discrimination against PLWHA, leads to an 
unwillingness to reveal HIV status and/or to undergo 
diagnostic and treatment procedures. Thus PLWHA 
not coming forward to access ARV services is deeply 
rooted in social fears, misconceptions and cultural 
believes. Poor information, fear of discrimination and 
stigmatization from the health personnel as well as the 
community are probably the key factors discouraging 
people from being tested and taking up treatment. 
Botswana faced a huge stigma problem that posed a 
barrier for patients who could not take their treatments at 
home or at work due to fear of detection and for patients 
who felt uncomfortable going to the hospital for testing 
and medication refi lls as a result of confi dentiality 
concerns25,26. 
In Nepal most of the people living with HIV/AIDS do 
not know if they are infected and so many PLWHA may 
continue to be engaging in unsafe sexual practices. This 
might be associated with stigma and discrimination 
against these people. Other high risk groups are also 
practicing these norms and do not go to test and seek 
treatment27. Thus, Nepalese people continue to perceive 
HIV/AIDS negatively. PLWHA hide their disease, due 
to the fear of the separation and the stigma sculptured 
by the mass media – i.e. HIV is a bad person’s disease. 
PLWHA and commercial sex workers are socially 
and culturally rejected as bad characters, something 
which directly hinders the utilization of ARV services. 
Elsewhere, in Senegal, patients hide their medicines 
due to some of their relatives are still reject them28.  
Socio-cultural factors are responsible to fuel the spread 
of HIV/AIDS in most societies at different levels 
ranging from individual to national and international 
which have signifi cant impacts on public health. The 
impact may be socio-cultural and psychological. 
Counselling enables a person to cope better with 
stressful situations, fi nd practical ways to solve 
problems and make positive decisions regarding own 
health. Counselling services have a pivotal role in HIV/
AIDS care29. HIV counselling and testing is a major 
starting point for accessing and being informed on HIV/
AIDS related services which will provide psychological 
support30. ARV centres need strong linkages with other 
clinical services with good referrals and good counselling 
services so that HIV positive people register for ARV 
before they reach the late stages of the infection. For 
good referral, counselling and testing can help promote 
greater social acceptance of PLWHA. It is argued that 
widespread uptake of VCT within communities can 
help “to normalise HIV/AIDS to reduce AIDS related 
stigma and to raise awareness of the epidemic”31 and 
represents a mechanism for referral into care and 
treatment in health centres32. VCT is viewed as a cost-
effective strategy that can serve as a gateway to most 
HIV-related services33.
Still Nepalese migrant workers communities have low 
awareness about HIV/AIDS. The study revealed that 
HIV/AIDS as a “Bombay disease” and still so many 
PLWHA are living with out adequate knowledge about 
counselling. Several reasons were associated with the 
limited number of people knowing their HIV status, 
disclosing their status and receiving ARV treatments. 
There are limited numbers of VCT sites and some 
people may not approach health facilities for testing 
312
HIV status and in some of the case people are interested 
to seek test but due to poor referral systems they do not 
reach the right place. 
However just expanding VCT sites and identifying 
more HIV positive or symptomatic people without 
having adequate treatment services will have a negative 
effect. By knowing their status, they will have emotional 
responses like anger, despair and even may attempt 
suicide. These emotional responses are normal but 
counselling can cope with some instances. 
3. Poor leadership 
Strong leadership at all levels of society is crucial for 
an effective response to the HIV/AIDS management. 
Leadership involves personal commitment and concrete 
actions but NCASC is functioning with instability at 
the top level of management (through frequent changes 
of director) which is hindering the programme’s 
effectiveness in the long term. According to UNGASS, 
NCASC is a poorly functioning national coordination 
mechanism which results in poor policy support34. 
Inspiring and empowering leadership at all levels is 
needed to transform the national response to HIV and 
AIDS from a plan into action. Respondents stated that 
instability at top level management in NCASC is the 
main problem to hindering further expansion of the 
programme.  
The majority of respondents stated that the HIV/
AIDS programme has still not matured due to frequent 
change of the NCASC director since its establishment 
and is directly affecting the continuity of programme 
implementation. It may have happened due to frequent 
changes of government and appointment of newly 
favoured persons due to changing of the health minister. 
Whilst HIV/AIDS is a prestigious programme which 
has a lot of opportunities to earn money, it is referred to 
as a “gold” programme. In this situation, there is a huge 
competition among government personnel to work in 
this position. 
Strengths and weaknesses
This in-depth interview study is the fi rst of its kind to 
bring together the views of the three key stakeholders 
regarding ARV in Nepal.  This study is the fi rst types 
of study in the fi eld of HIV/AIDS treatment program in 
Nepal from a management perspectives and which opens 
a new gateway for further research. All issues were 
discussed in Nepali language, where all interviewees 
were actively discussing the issues in natural settings in 
mother tongue which is strength of this study. 
The study has used a qualitative approach with purposive 
sampling technique. Due to limitations of time and 
resources we have not included all Nepalese ARV sites 
in this study. More importantly, our study only included 
PLWHA who were currently receiving ARV, ignoring 
PLWHA who were not receiving treatment. There are 
limitations to the epidemiological data that is currently 
available as it is inconsistent and lacking in uniformity. 
The study has only interviewed the male clients and did 
not include the female clients which might infl uence 
the situation of female PLWHA. However, in spite of 
these various limitations, approaching a wide-range of 
different participants and interviewing them gave us a 
comprehensive set of results.   
Conclusions 
Our study revealed that making ARV treatment services 
available and to expand ARV sites to all ARV eligible 
people in Nepal is associated with a range of problems 
and barriers.  
DOTS has a good track  record for tuberculosis control 
in Nepal and if the same model for the delivery of ARV 
treatment services can be made to work at a national 
level, many lives can be saved and the risk of drugs 
resistance kept low.  There is currently a lack of 
effective comprehensive ARV provision, especially 
of programmes that can engage HIV infected people 
as participants in a full array of treatment services. 
Efforts to expand ARV services requires a collaborative 
approach of involving policy level and all stakeholders 
(health workers, NGOs/INGOs and PLWHAs). There is 
urgent need to address those problems and strengthen the 
whole spectrums of health systems through collaborative 
approach for making ARV services available to all 
ARV eligible people. This raises the questions towards 
achievement of the millennium development goals to 
halt and reverse the spread of HIV/AIDS by 2015.
Recommendations
It is necessary to strengthen and expand infrastructure 
(e.g. adequate rooms in existing ARV sites), provide 
diagnostic facilities in all regional, zonal and district 
hospitals and make existing ARV sites a “centre of 
excellence” in a central hospital as well as “one-stop-
care” centres. 
Perhaps it is possible to establish a system to collect 
specimen and send these for CD4 cell count in central 
laboratory rather than sending patients themselves for a 
CD4 test to Kathmandu.
Frequently unavailability of trained health personnel in 
and outside Kathmandu is one of the main problems. 
Thus, it is necessary to fi nd out the cause and make a 
“package policy” to address why these personnel are 
frequently leaving their allotted place.
It is necessary to ensure the stability of top level 
management of NCASC and reduce the frequent 
replacement.
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NGOs should work at community level aimed at 
mitigating stigma and discrimination in an effort to 
create an environment where PLWHA can take ARVs 
without fear.
As this study was done with a small sample size for 
limited time period therefore it is necessary to conduct 
a large scale and more representative quantitative study 
with a variety of health professionals, private (NGOS/
INGOs) representatives, more PLWHA on ARV and 
also including the family members of PLWHA. 
In order to minimize the fi nancial burden to PLWHAs, 
there should be either provision for allowances to 
receive ARV drugs or ARV treatment should consider 
home delivery by NGOs. Although we recognise that 
this in itself may increase the risk of stigma for PLWHA 
in their own community.
Perhaps it is possible to accurately determine the number 
of ARV eligible clients (epidemiology) in Nepal and 
the main areas in which they live in order to develop a 
planned ARV services. 
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